UK-based digital diagnostics platform Bloodtest.co.uk has secured a £3 million investment from an American private equity group, valuing the company at £15 million. The funding highlights growing investor confidence in the private healthcare and health-tech sectors, particularly in digital diagnostics.
Founded in 2023 by entrepreneur Giles Meadows, Bloodtest.co.uk began as a bedroom startup and hopes to grow into one of the UK’s fastest-growing platforms for private blood testing and AI-driven aftercare. The business offers fast and convenient access to blood tests, enabling individuals to manage their health outside the traditional healthcare system proactively.
“This is a huge moment for us,” said Giles, Founder of Bloodtest.co.uk. “It’s been many months in the making to secure this investment, and it’s encouraging to work with people who understand where we want to position the company. Their belief in our mission and approach means a lot — this is just the beginning.”
A spokesperson for the American investment team commented:
“We’re seeing sustained growth in demand for private healthcare services, particularly in markets like the UK, where innovation is reshaping access and delivery. What impressed us about Bloodtest.co.uk was not only its market traction but also the strength of its technical vision, particularly the integration of AI-powered Aftercare. This is a company solving real problems in a modern way, and we are excited to support the next phase of its growth.”
The investment will be used to:
• Enhance Bloodtest.co.uk’s digital platform
• Expand the diagnostics offering
• Increase marketing and user acquisition
• Grow commercial partnerships with healthcare providers and insurers
With the UK health-tech market continuing to expand rapidly, Bloodtest.co.uk is positioning itself at the forefront of accessible, technology-driven healthcare.
